Strategies for Managing Depression Refractory to Selective Serotonin Reuptake Inhibitor Treatment: A Survey of Clinicians
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
1996 • 764 citations
A Placebo-Controlled Comparison of Lithium and Triiodothyronine Augmentation of Tricyclic Antidepressants in Unipolar Refractory Depression
1993 • 267 citations
Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study
1994 • 230 citations
Treatments of Psychiatric Disorders
1996 • 214 citations
Paroxetine and pindolol
1997 • 164 citations
Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy
1997 • 161 citations
Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.
1996 • 134 citations
Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
1993 • 132 citations
An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression.
1993 • 111 citations
What constitutes an adequate antidepressant trial for fluoxetine?
1990 • 106 citations
Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol
1997 • 102 citations
Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia
1996 • 99 citations
(−)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
1996 • 77 citations
Combined treatment strategies in psychiatry.
1993 • 50 citations
Continuation and Maintenance Treatments of Major Depressive Disorder
1994 • 48 citations
Lithium augmentation in sertraline‐resistant depression: a preliminary dose‐response study
1993 • 42 citations
Dr. Stoll and Colleagues Reply
1996 • 38 citations
Comparison of two dosage regimens of fluoxetine in major depression.
1985 • 34 citations
Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression.
1997 • 34 citations
An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder.
1996 • 33 citations
Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists
1997 • 33 citations
Psychiatrists' responses to failure of maintenance therapy with antidepressants
1997 • 30 citations
A Review of the Use of Augmentation Therapy for the Treatment of Resistant Depression: Implications for the Clinician
1997 • 20 citations
Strategies for Augmentation of SSRI Treatment: A Survey of an Academic Psychopharmacology Practice
1999 • 18 citations
329. Seizures associated with bupropion and SSRI co-therapy
1998 • 8 citations